[ON MEASUREMENT OF THE CONCENTRATION OF DL-GLYCERALDEHYDE IN THE BLOOD OR INFUCOLL-BLOOD MIXTURES AND ON DETERMINATION OF THE EFFECTIVE DOSE IN CANCER THERAPY FROM SUCH MEASUREMENTS].
D000970:Antineoplastic Agents; D005985:Glyceraldehyde; D006801:Humans; D009369:Neoplasms; D010952:Plasma Substitutes
D000970:Antineoplastic Agents; D010952:Plasma Substitutes; D005985:Glyceraldehyde
ANTINEOPLASTIC AGENTS; GLYCERALDEHYDE; PLASMA SUBSTITUTES
ZUR MESSUNG DER KONZENTRATION VON DL-GLYCERINALDEHYD IN BLUT BZW. INFUCOLL-BLUTGEMISCHEN UND ZUR BESTIMMUNG DER KREBSTHERAPIE-WIRKDOSIS AUS SOLCHEN MESSUNGEN.